Kodiak Sciences Inc

K27

Company Profile

  • Business description

    Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.

  • Contact

    1200 Page Mill Road
    Palo AltoCA94304
    USA

    T: +1 650 281-0850

    E: [email protected]

    https://www.kodiak.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    109

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,510.7043.700.52%
CAC 407,873.8323.730.30%
DAX 4023,638.5672.020.31%
Dow JONES (US)42,140.43269.67-0.64%
FTSE 1008,602.922.06-0.02%
HKSE23,108.27441.19-1.87%
NASDAQ19,010.09301.741.61%
Nikkei 22538,183.26539.001.43%
NZX 50 Index12,781.185.56-0.04%
S&P 5005,886.5542.360.72%
S&P/ASX 2008,269.0035.500.43%
SSE Composite Index3,374.875.630.17%

Market Movers